clear cell renal cell carcinoma
Showing 76 - 100 of 101
Samples From Younger Patients With Kidney Cancer
Withdrawn
- Childhood Kidney Neoplasm
- +3 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Aug 3, 2018
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Charleston (Nivolumab, Ipilimumab, Steriotactic
Withdrawn
- Clear Cell Renal Cell Carcinoma
- Metastatic Renal Cell Carcinoma
- Nivolumab
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Jun 14, 2018
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Cleveland (tandutinib,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- tandutinib
- laboratory biomarker analysis
-
Cleveland, OhioCase Western Reserve University
Oct 19, 2017
Adult Solid Tumor, Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma Trial in Madison (Computed Tomography,
Completed
- Adult Solid Neoplasm
- +4 more
- Computed Tomography
- +5 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Oct 9, 2017
Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,
Completed
- Childhood Renal Cell Carcinoma
- +12 more
- Doxorubicin Hydrochloride
- +9 more
-
Birmingham, Alabama
- +186 more
Jun 22, 2017
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (drug, other,
Terminated
- Clear Cell Renal Cell Carcinoma
- +2 more
- pazopanib hydrochloride
- +3 more
-
Chicago, Illinois
- +3 more
May 8, 2017
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Stanford (radiation, drug,
Terminated
- Clear Cell Renal Cell Carcinoma
- +2 more
- stereotactic body radiation therapy
- +3 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Mar 13, 2017
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Canada (Gamma-Secretase
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- Gamma-Secretase Inhibitor RO4929097
- Laboratory Biomarker Analysis
-
Vancouver, British Columbia, Canada
- +3 more
Jan 19, 2017
Clear Cell Renal Cell Carcinoma Trial in Houston (G-202)
Completed
- Clear Cell Renal Cell Carcinoma
-
Houston, TexasUniversity of Texas Health Science Center, Houston
Feb 22, 2017
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Houston (drug, biological,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- Sorafenib Tosylate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 28, 2016
Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma Trial in France, Germany, United States
Completed
- Renal Cell Adenocarcinoma
- +3 more
- AMG 172
-
Scottsdale, Arizona
- +3 more
Mar 23, 2016
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Cleveland (Stereotactic Radiosurgery, Pazopanib Hydrochloride)
Withdrawn
- Clear Cell Renal Cell Carcinoma
- Renal Cell Carcinoma
- Stereotactic Radiosurgery
- Pazopanib Hydrochloride
-
Cleveland, Ohio
- +1 more
Mar 1, 2016
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Baltimore, Salisbury, Madison
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
-
Baltimore, Maryland
- +2 more
Dec 10, 2015
Various Chemokines in the Detection and Follow up of RCC
Unknown status
- Clear Cell Renal Cell Carcinoma
- patients with renal cell carcinoma
-
Haifa, IsraelCarmel Medical Center
Mar 4, 2015
Clear Cell Renal Cell Carcinoma Trial in Auckland (Dovitinib)
Unknown status
- Clear Cell Renal Cell Carcinoma
-
Auckland, New ZealandAuckland Hospital
Feb 1, 2015
Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in Boston, Philadelphia,
Completed
- Chromophobe Renal Cell Carcinoma
- +5 more
- Bevacizumab
- +3 more
-
Boston, Massachusetts
- +4 more
Jan 6, 2015
Patient Satisfaction With Oral Anti-Cancer Treatment
Completed
- Clear Cell Renal Cell Carcinoma
-
Leuven, BelgiumKatholieke Universiteit Leuven - Klinische Farmacologie en Farma
Sep 19, 2014
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Chicago (cediranib maleate,
Terminated
- Clear Cell Renal Cell Carcinoma
- +2 more
- cediranib maleate
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago
May 5, 2014
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer Trial in Baltimore, Madison (drug,
Completed
- Clear Cell Renal Cell Carcinoma
- +6 more
- sunitinib malate
- +6 more
-
Baltimore, Maryland
- +1 more
Apr 1, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014
Clear Cell Renal Cell Carcinoma Trial in Nijmegen (Sorafenib, 111Indium-bevacizumab, 111Indium-cG250)
Completed
- Clear Cell Renal Cell Carcinoma
- Sorafenib
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboud University Nijmegen Medical Center
Nov 29, 2013
Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Cancer Trial in Durham (drug, biological,
Terminated
- Clear Cell Renal Cell Carcinoma
- +4 more
- sorafenib tosylate
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jul 1, 2013
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Chicago (ixabepilone,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- ixabepilone
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Mar 22, 2013
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in San Antonio (drug,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- sorafenib tosylate
- +2 more
-
San Antonio, TexasSouthwest Oncology Group
Feb 27, 2013